Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for CNV in Angioid Streaks
NCT01015495Phase 2Withdrawn
- Sponsor
- University of Illinois Chicago
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of ranibizumab in angioid streaks, sponsored by University of Illinois Chicago. Planned start Dec 2009; status: withdrawn.
02
Drugs
ranibizumab
03
Conditions
angioid streaks
Beyond the preview
Go deeper on NCT01015495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015495.